Crinetics Pharmaceuticals Inc. (CRNX) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crinetics Pharmaceuticals...

    NASDAQ: CRNX · Real-Time Price · USD
    36.64
    1.50 (4.27%)
    At close: Sep 09, 2025, 2:44 PM

    Crinetics Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -298.41M -214.53M -163.92M -107.64M
    Depreciation & Amortization
    		 2.79M 1.1M 983K 922K
    Stock-Based Compensation
    		 69.39M 40.94M 28.27M 17.35M
    Other Working Capital
    		 -5.91M -6.6M 7.62M -5.2M
    Other Non-Cash Items
    		 -11.37M 26.63M 850K -739K
    Deferred Income Tax
    		 n/a -28.48M n/a 422K
    Change in Working Capital
    		 11.63M 8.04M 18.61M 1.1M
    Operating Cash Flow
    		 -225.97M -166.31M -115.2M -88.59M
    Capital Expenditures
    		 -3.84M -4.69M -1.66M -436K
    Cash Acquisitions
    		 n/a 195.72M 34K 422K
    Purchase of Investments
    		 -1.16B -532.86M -329.82M -125.4M
    Sales Maturities Of Investments
    		 575.8M 337.13M 157.49M 69.36M
    Other Investing Acitivies
    		 14.93M -195.72M -34K -422K
    Investing Cash Flow
    		 -574.82M -200.41M -173.98M -56.48M
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 40.39M 19.93M 4.72M 3.14M
    Financial Cash Flow
    		 1.01B 388.94M 121.96M 252.68M
    Net Cash Flow
    		 209.65M 22.22M -167.22M 107.61M
    Free Cash Flow
    		 -229.81M -171M -116.86M -89.02M

    Add to Watchlist